Addressing poverty-related diseases with sustainable
and paradigm-shifting innovations.


Get in touch

Tupolevlaan 73
1119PA Schiphol-Rijk
The Netherlands

Investment FAQs

Landcent is currently raising funds complete the final phase R&D and semi-field trials of our next-generation malaria prevention technologies. Our investors will contribute to unlocking $4 trillion of economic potential.

What are you raising funds towards?

Landcent is raising funds for the final product certification and qualification, towards market entry in 2025.

Explain the business model

The World Health Organization (WHO) African Region is our target market. Once our products are qualified by the WHO, customers such as The Global Fund, President's Malaria Initiative, UNICEF, World Vision etc. purchase the products from us for distribution across Africa.

What is the market size for malaria prevention?

There is a market of €855M for our 3 vector control tools - LLINs, IRS, and Anti-malarial Pills. Our emerging solutions (repellents, larvicides) & active ingredients for vector control would significantly expand this market size.

What form of capital are you raising?

This round of funding is an all equity raise

When does the funding round close?

This final round of funding closes Q4, 2023

Reach Out

For any enquiries regarding our solutions, distribution or investment opportunities

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.